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Determination of Fentanyl in Canine Plasma using HPLC-MS Detection
Joan Bailey1, Molly White1, Kristen Gordon1, Reza Seddighi2, Sherry Cox1 • 1Department of Biomedical & Diagnostic Sciences and 2Department of Small Animal Clinical Sciences • The University of
Tennessee College of Veterinary Medicine • Knoxville, TN 37996

ABSTRACT
A simple, easy, and accurate high-performance liquid chromatographic method for
the determination of fentanyl concentrations in plasma samples has been developed
and validated. Following a liquid extraction with acetonitrile, samples were separated
by reversed-phase high-performance liquid chromatography (HPLC) on an XBridge C18
column (2.1 x 50 mm, 3.5µm) and detected by mass spectroscopy. The mobile phase
was a mixture of water with 0.1% formic acid, and acetonitrile with 0.1% formic acid
(90:10), with a flow rate of 0.6 ml/min. The procedure produced a linear curve over
the concentration range of 0.1-25 ng/ml for fentanyl in canine plasma with a LOQ of
0.1 ng/ml. Intra- and inter-assay variability ranged from 2.6%-8.2% and the average
recovery for fentanyl was 100%.

Figure 1
Chromatograms for Fentanyl in K9 plasma

Figure 2
Chromatograms for Flurazepam (I.S.) in K9
plasma

A: Blank K9 plasma sample

A: Blank K9 plasma sample

Table 3: Fentanyl freeze-thaw stability

Figure 3: Pharmacokinetic profile of fentanyl in canine plasma

B: Spiked 2.5 ng/ml K9 plasma standard

B: Spiked 2.5 ng/ml K9 plasma standard

Chromatographic Conditions

INTRODUCTION
Fentanyl, N-(1-phenethyl-4-piperidyl) propionanilide, is a synthetic opioid which has
a high affinity for µ-opioid receptors. Fentanyl injection and transdermal patches are
used primarily in dogs and cats and have been shown to be useful for the adjunctive
control of postoperative pain and in the control of severe pain associated with chronic
pain, dull pain, and non-specific, widespread pain associated with cancer, pancreatitis,
aortic thromboemboli, and peritonitis. Perioperative injectable fentanyl may also
reduce the requirements for inhalational anesthetics during surgery, which could be
particularly advantageous in patients with compromised cardiac function. Fentanyl
levels have been determined using mass spec and ultraviolet detection in plasma
blood, urine, and saliva. Many extraction methods have been reported including solid
phase extraction, and liquid-liquid extractions. This paper describes a simple, sensitive,
and accurate method for extracting fentanyl from plasma samples using HPLC.

C: Canine plasma sample Sherman 90 min after
fentanyl administration

C: Canine plasma sample Sherman 90 min
after fentanyl administration

Sample Treatment
Fentanyl was extracted from plasma samples using a liquid extraction with
acetonitrile. Previously frozen plasma samples were thawed and vortexed and 100 µl
was transferred to a 7 ml glass screw top tube then 25 µl of internal standard (0.1
µg/ml flurazepam) added. One milliliter of acetonitrile was added and tubes were
capped and vortexed for 60 s then centrifuged for 20 min at 1020 x g. The
supernatant was removed and placed in a clean glass tube and evaporated to
dryness with nitrogen gas. Samples were reconstituted in 200 µl of mobile phase and
50 µl injected into the HPLC system.

MATERIALS and METHODS
Reagents and Standards
Fentanyl was purchased from USP. Flurazepam, the internal standard, was
purchased from Cerilliant. All reagent grade chemicals and solvents were purchased
from Fisher Scientific. Water (18.2 megaohm) was obtained from a Barnstead
Micropure Infinity ultrapure water system. Stock solutions of fentanyl and flurazepam
(100 µg/ml) were prepared in methanol. Dilutions were prepared to produce working
stock standards of 0.01, 0.1, and 1 µg/ml. The standards were stored at 4°C and were
stable for a minimum of 6 months. Standard curves for plasma were prepared by
spiking untreated plasma with fentanyl which produced a linear concentration range
of 0.1 to 25 ng/ml. Spiked standards were treated exactly as plasma samples.
For stability testing, canine plasma (400 µL) was spiked with fentanyl at
concentrations 0.3, 0.75, and 17.5 ng/ml. A 100 µL sample was pulled from this spiked
plasma and analyzed immediately. The remaining spiked plasma was then frozen in an
-80˚C freezer, thawed, and another 100 µL sample was analyzed. This process was
repeated for a total of three freeze-thaw cycles. The results were then compared to
the initial analysis.

Chromatographic Conditions

The analysis of fentanyl in plasma was conducted using reverse phase HPLC. The
chromatography system consisted of a 2695 separation module and an Acuity QDa
single-quadrupole mass detector (Waters). Separation was achieved on a Waters
XBridge C18 column (2.1 x 50 mm, 3.5 µm) preceded by a XBridge C18 guard column.

The mobile phase was a mixture of (A): water with 0.1% formic acid and (B)
acetonitrile with 0.1% formic acid. The mixture was pumped at a starting gradient of
90% A and 10% B and was adjusted to 10% A and 90% B over 4 min, and back to
initial conditions over 4 min. The flow rate was 0.60 ml/min, and the column
temperature was ambient which was 30˚C. The compounds were detected by positive
selected ion recording (SIR). The scan rate was 2 pts/s, gain 1, capillary voltage 0.8 kV,
cone voltage 15, ion source temperature 150˚C and probe temperature 600˚C.
Nitrogen was used as the nebulizing gas. Fentanyl was detected at 337.34 m/z and
flurazepam was detected at 388.24 m/z.

Table 1. Fentanyl assay linearity

Assay linearity (n=5)
Mean ± STD

RSD (%)

Slope

0.1749 ± 0.0062

3.5

Y-intercept

0.0047 ± 0.0003

6.19

R2

0.9996 ± 0.0002

0.02

Table 2. Intra-assay and Inter-assay
accuracy and precision for fentanyl in
plasma.

Intra assay variability (n=5)
Concentration Concentration measured
(ng/ml)
(ng/ml)
(mean ± SD)

RSD
(%)

0.3

0.3 ± 0.02

6.6

0.75

0.73 ± 0.05

7

17.5

17.8 ± 0.58

3

Inter assay variability (n=5)
Concentration Concentration measured
(ng/ml)
(ng/ml)
(mean ± SD)

RSD
(%)

0.3

0.28 ± 0.02

7.5

0.75

0.77 ± 0.06

8.2

17.5

17.0 ± 0.44

2.6

SD, standard deviation; n, number of days or samples

RESULTS and CONCLUSIONS
Testing of blank and spiked canine plasma revealed no interferences for fentanyl
or flurazepam. Figs. 1 & 2 show chromatograms of a (A) blank plasma sample, (B) a
2.5 ng/ml spiked dog plasma standard and (C) a dog plasma sample after fentanyl
administration. Retention times were 3.22 min for fentanyl and 3.28 min for
flurazepam. The plasma peak ratio (area of fentanyl divided by the internal standard
area) produced a linear curve for the concentration range 0.1-25 ng/mL with a
correlation coefficient of >0.99 (Table 1), and having a LOD of 0.05 ng/mL and LOQ
of 0.1 ng/ml. Intra- and inter-day assay relative standard deviation (RSD) for plasma
spiked with fentanyl were used to determine accuracy and precision which ranged
from 2.6% to 8.2% (Table 2). The precision was found to be below ± 15% for all
quality control samples. The average recovery for fentanyl was 100%. Stability of
fentanyl under freeze-thaw conditions was tested and resulted in an average 2% loss
after three cycles (Table 3).
In conclusion, this HPLC method quantifies fentanyl from plasma by combining a
liquid extraction procedure with mass spectroscopy. This analytical procedure was
validated in terms of recovery, linearity, LOQ, precision, and accuracy. This method
utilizes a small sample size of 100 µL making it potentially useful for small dogs, cats
or other small animals. Fig 3 is a representative concentration-time profile from a
fentanyl pharmacokinetic study.

